Blood pressure behavior during exercise in patients with diastolic dysfunction and a hypertensive response to exercise
The Journal of Clinical Hypertension · 2024
DOI: 10.1111/jch.14884 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Journal of Clinical Hypertension, 2024. Verfasst von Laura Würzburger und 12 weiteren Autor:innen. Beteiligte Einrichtung: University Heart Center, University Hospital Zurich, Zurich, Switzerland. Hauptthemen laut MEDLINE: Hypertension, Blood Pressure, Exercise, Echocardiography. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
A hypertensive response to exercise is a precursor leading to hypertension, which is a major risk factor for the development of heart failure and diastolic dysfunction. Herein, we aimed to assess blood pressure (BP) in patients with a hypertensive response to exercise and different degrees of diastolic dysfunction. Between January 2009 and December 2014, 373 patients with a hypertensive response to exercise (HRE) and echocardiographic data assessing diastolic function were enrolled at the University Hospital of Zurich. ANCOVA was used to assess the changes in BP response during exercise testing in individuals with different degrees of diastolic dysfunction. Normalization of systolic BP was blunted in patients with grade II and III diastolic dysfunction after 3 min of recovery in univariable [β (95%) ‐ 9.2 (‐13.8 to ‐ 4.8) p < .001, ‐16.0 (‐23.0 to 9.0) p < .001, respectively] and adjusted models. In fully adjusted models, when taking maximal effort into account, there were no differences with regard to systolic BP during exercise. Patients without diastolic dysfunction achieved higher heart rates (HRs) [both in absolute terms ( p < .001) and as a percentage of the calculated maximum ( p = .003)] and greater wattage ( p < .001) at maximum exertion. The findings of this cross‐sectional study suggest that exercise capacity is compromised in patients with diastolic dysfunction. A hypertensive response to exercise and the finding of a blunted BP recovery may help identify patients at risk of developing heart failure.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- University Heart Center, University Hospital Zurich, Zurich, Switzerland.
- Cardiology, University Hospital Basel, Cardiovascular Research Institute Basel, Basel, Switzerland.
- Hochgebirgsklinik, Medicine Campus Davos, Davos, Switzerland.
- Center of Translational and Experimental Cardiology, University Hospital Zurich, Zurich, Switzerland.
- Herzgefaesszentrum im Park, Hirslanden Klinik im Park, Zurich, Switzerland.
- Christine Kühne Center for Allergy Research and Education (CK-CARE), Medicine Campus Davos, Davos, Switzerland.
ORCID-Profile: David Niederseer
Zitieren
APA
Würzburger, L., van der Stouwe, J. G., Ghidoni, C., Wiech, P., Moser, G., Petrasch, G., Schweiger, V., Bohm, P., Rossi, V. A., Templin, C., Caselli, S., Schmied, C. M., & Niederseer, D. (2024). Blood pressure behavior during exercise in patients with diastolic dysfunction and a hypertensive response to exercise. The Journal of Clinical Hypertension. https://doi.org/10.1111/jch.14884
Vancouver
Würzburger L, van der Stouwe JG, Ghidoni C, Wiech P, Moser G, Petrasch G, et al. Blood pressure behavior during exercise in patients with diastolic dysfunction and a hypertensive response to exercise. The Journal of Clinical Hypertension. 2024. doi:10.1111/jch.14884
BibTeX
@article{Wrzburger2024,
author = {Würzburger, Laura and van der Stouwe, Jan Gerrit and Ghidoni, Céline and Wiech, Patrick and Moser, Georg and Petrasch, Gloria and Schweiger, Victor and Bohm, Philipp and Rossi, Valentina A and Templin, Christian and Caselli, Stefano and Schmied, Christian M and Niederseer, David},
title = {Blood pressure behavior during exercise in patients with diastolic dysfunction and a hypertensive response to exercise},
journal = {The Journal of Clinical Hypertension},
year = {2024},
doi = {10.1111/jch.14884}
}
EUVIMED